In vitro model of production of antibodies; a new approach to reveal the presence of key bacteria in polymicrobial environments

Abstract

BackgroundThere is a rapid emergence of multiple resistant gram-negative bacteria due to overuse of antibiotics in the treatment of infections. Biofilms consist of polymicrobial communities that survive the host’s defense system. The key bacteria in biofilms are slow growing and support an attachment and rapid growth of other microorganisms. Current antimicrobial strategies often fail due to poor diagnosis of key pathogens in biofilms.The study aims to develop anti-bacterial human antibodies in vitro from patients who had recently undergone a systemic infection by pathogenic bacteria and to use these antibodies as a tool for detecting bacteria in biofilms.MethodsLymphocytes were separated from whole blood of patients (n = 10) and stimulated with heat-killed bacteria to produce antibodies in vitro. The specificity of antibodies in recognizing the bacteria against which they were directed was evaluated by surface plasmon resonance system (SPR) and electron microscopy. The ulcer secretions from patients with chronic and acute leg ulcers and healthy controls were analyzed by the SPR system and the results were compared with culture studies.ResultsThe produced antibodies recognized bacteria with high sensitivity (SPR). The antibodies against Enterococcus fecalis bound specifically to the microorganism in a bacterial co-culture that was visualized by electron microscopy.ConclusionIn the present work, a method for producing specific antibodies against bacteria is introduced to recognize bacterial components in body fluids of patients suffering from pathogenic biofilms. This diagnostic technique may be most useful in clinical microbiology and in the choice of antibiotics in the treatment of serious infections.Electronic supplementary materialThe online version of this article (doi:10.1186/s12866-016-0821-5) contains supplementary material, which is available to authorized users.

Pyrazolyl Thioureas and Carbothioamides with an NNSN Motif against MSSA and MRSA

“…4 One of the major reasons for the lack of suitable drug candidates is that there is practically no academic discovery pipeline in the United States because of insufficient funding. 9 Novel approaches to treat infectious diseases, for instance, the discovery and up-scaling of antibodies against bacterial pathogens, 11,12 and identifying novel antibiotics through genomic mining 13,14 are still in their infancy.…”

A Pilot Evaluation of a Rapid Screening Test for Nosocomial Meningitis or Pneumonia at a Neurosurgical Intensive Care Unit in Sweden

“…Systemic inflammatory response markers such as C-reactive protein (CRP) and procalcitonin may or may not be elevated and do not indicate the site of infection [11].Conventional bacterial cultures have low sensitivity to detect an infection due to antibiotic prophylaxis in severe cases or to the fact that nosocomial infections are commonly caused by slow-growing opportunistic bacteria [12]. Furthermore, such infections do not induce CRP or procalcitonin elevation in all of the cases [13].…”